Vitamin D control of osteoblast function and bone extracellular matrix mineralization

Critical Reviews in Eukaryotic Gene Expression

Volumn 11, Issue 1-3, 2001, Pages 199-226

  Van Leeuwen, J P T M ^a   Van Driel, M ^a   Van Den Bemd, G J C M ^a   Pols, H A P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bone; Matrix proteins; Mineralization; Osteoblast; Vitamin D; Vitamin D receptor

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 1; MATRIX PROTEIN; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; PLASMINOGEN; PROSTAGLANDIN; SIALOPROTEIN; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D; VITAMIN D RECEPTOR;

BONE MINERALIZATION; CALCIUM DEFICIENCY; CALCIUM HOMEOSTASIS; CELL FUNCTION; EXTRACELLULAR MATRIX; GENE EXPRESSION SYSTEM; KNOCKOUT MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RICKETS; VITAMIN D METABOLISM;

ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; BONE MORPHOGENETIC PROTEINS; CALCIFEDIOL; CALCIFICATION, PHYSIOLOGIC; CALCITRIOL; CALCIUM-BINDING PROTEINS; CELL DIVISION; CELL LINE; CYTOCHROME P-450 ENZYME SYSTEM; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, KNOCKOUT; MINERALS; OSTEOBLASTS; OSTEOCALCIN; OSTEOCLASTS; OSTEONECTIN; OSTEOPONTIN; OSTEOPOROSIS; PLASMINOGEN; PROSTAGLANDINS; RATS; RECEPTORS, CALCITRIOL; RICKETS; SIALOGLYCOPROTEINS; STEROID HYDROXYLASES; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 0034776264     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (311)

1. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII)
2. The plasminogen activator inhibitor system in bone cell function
3. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation
4. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses
5. Mechanism of mineral formation in bone
6. Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells
7. 3 is regulated by parathyroid hormone in UMR106 osteoblastic cells
8. The heterogeneity of the osteoblast phenotype
9. Calbindin-D9K immunolocalization and vitamin D-dependence in the bone of growing and adult rats
10. Longterm nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D
11. 3
12. 3
13. Developmental expression and hormonal regulation of the rat matrix Gla protein (MGP) gene in chondrogenesis and osteogenesis
14. Apoptosis induction of POS canine osteosarcoma cells by vitamin D and retinoids
15. Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts
16. 3 inhibition of col1a1 promoter expression in calvariae from neonatal transgenic mice
17. 3
18. 3 stimulates adipocyte differentiation in cultures of fetal rat calvaria cells: Comparison with the effects of dexamethasone
19. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures
20. 3, parathyroid hormone, and glucocorticoids
21. 3 on osteogenic differentiation of human marrow stromal cells in vitro
22. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription
23. Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D: Documentation and effective therapy with high dose intravenous calcium infusions
24. Establishment and hormonal regulation of a conditionally transformed preosteocytic cell line from adult human bone
25. 3 on collagen type I, osteopontin, and osteocalcin gene expression in chicken osteoblasts
26. Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae
27. Molecular structure, chromosome assignment, and promoter organization of the human matrix Gla protein gene
28. 3: A steroid hormone capable of producing pleiotropic receptor-mediated biological responses by both genomic and nongenomic mechanisms
29. Two nuclear signalling pathways for vitamin D
30. 3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: Homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors
31. 3 and calcium to prevent hip fractures in the elderly women
32. Modulation of intestinal vitamin D receptor by ovariectomy, estrogen and growth hormone
33. 3 in rat bone organ cultures
34. 3 and glucocorticoids on the growth of rat and mouse osteoblast-like bone cells
35. 3 and its interaction with glucocorticoids
36. 3 receptors and bioresponse in bone cells: Species differences between rat and mouse
37. 3 in cultured mouse osteoblast-like cells - Modulation by changes in receptor level
38. 3 receptor levels and augments bioresponses in rat osteoblast-like cells
39. 3 and dexamethasone on rat osteoblast-like primary cell cultures: Receptor occupancy and functional expression patterns for three different bioresponses
40. 3 modulation of insulin-like growth factor-binding proteins in rat osteoblast-like cell cultures
41. Hormonal regulation of the osteoblastic phenotype expression in neonatal murine calvarial cells
42. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone
43. 3 and activity on human osteoblast-like cells in short-term cultures
44. Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T3-E1 cells
45. Biochemical markers of bone metabolism: An overview
46. Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells
47. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes
48. Insulin-like growth factor binding protein proteolysis in bone cell models
49. 3 receptor in rats
50. 3 in T-47D human breast cancer cells
51. 2+ transport)
52. Osteopenia and decreased bone formation in osteonectin-deficient mice
53. 3
54. Increased bone formation in osteocalcin-deficient mice
55. The osteoblast: A sophisticated fibroblast under central surveillance
56. 3 down-regulates expression of Phex, a marker of the mature osteoblast
57. Murine osteoblast-like cells and the osteogenic cell MC3T3-E1 release a macrophage colony-stimulating activity in culture
58. 3 on bone
59. 3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow
60. 3 receptors in T 47D breast cancer cells
61. Protein kinase C in transmembrane signalling
62. 3 on bone morphogenetic protein-3 mRNA expression
63. Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor β in rat bone: Possible mechanism for impaired osteoinduction
64. Vitamin D receptors: Not just in the nucleus anymore
65. 3 in human osteosarcoma cells
66. 3 and ascorbic acid in bone-derived cells
67. Is there a differential response to alfacalcidol and vitamin D in the treatment of osteoporosis?
68. 3 stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines
69. 3 treatment of osteosarcoma cells
70. Vitamin D in the treatment of osteoporosis
71. Vitamin D in the treatment of osteoporosis revisited
72. The role of vitamin D in the pathogenesis and treatment of osteoporosis
73. The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency
74. Bone sialoprotein
75. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage
76. Homologous up-regulation of vitamin D receptors is tissue specific in the rat
77. Expression of differentiated function by mineralizing cultures of chicken osteoblasts
78. Variable hormone responsiveness of osteoblast populations isolated at different stages of embryogenesis and its relationship to the osteogenic lineage
79. Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1
80. Regulation of osteoclast activity
81. Differential stimulation by PGE(2) and calcemic hormones of IL-6 in stromal/osteoblastic cells
82. Histone acetylation in chromatin structure and transcription
83. Characterization of osteoblast-like cells from normal adult rat femoral trabecular bone
84. Regulation of plasminogen activator production by bone-resorbing hormones in normal and malignant osteoblasts
85. Stimulation of plasminogen activator in osteoblast-like cells by bone-resorbing hormones
86. Natural metabolites of 1α,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor
87. 3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8
88. TGF-β and calcitriol
89. 3 in the human prostatic carcinoma cell line ALVA-31
90. Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma
91. Regulation of the production of plasminogen activators by bone resorption enhancing and inhibiting factors in three types of osteoblast-like cells
92. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines
93. Initiation of osteoclast bone resorption by interstitial collagenase
94. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors
95. Osteotropic agents induce the differential secretion of granulocyte-macrophage colony-stimulating factor by the osteoblast cell line MC3T3-E1
96. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
97. Secretion of osteocalcin and its propeptide from human osteoblastic cells: Dissociation of the secretory patterns of osteocalcin and its propeptide
98. New face of an old enzyme-alkaline phosphatase may contribute to human tissue aging by inducing tissue hardening and calcification
99. Calcium in osteoblast-enriched bone cells
100. 3 on the function, cytochemistry and morphology of normal human osteoblast-like cells
101. 3 in human osteosarcoma-derived osteoblast-like cells
102. 3-induced inhibition of bone nodule formation in long-term cultures of fetal rat calvaria cells
103. 3 on growth factor secretion in co-cultures of osteoblasts and endothelial cells
104. Regulation of NGF, BDNF and LNGFR gene expression in ROS 17/2.8 cells
105. Coactivators and corepressors as mediators of nuclear receptor function: An update
106. Interleukin 1 regulates the expression of osteopontin mRNA by osteoblasts
107. Human vitamin D receptor-dependent transactivation in Saccharomyces cerevisiae requires retinoid X receptor
108. 3 receptor in fetal rat bone
109. 3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro
110. Identification of a vitamin D receptor homodimer-type response element in the rat calcitriol 24-hydroxylase gene promoter
111. 3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes
112. 3 inhibits parathyroid hormone-related peptide mRNA expression in fetal rat long bones in culture
113. Endothelin-1 is a potent regulator of human bone cell metabolism in vitro
114. Production and action of transforming growth factor-β in human osteoblast cultures: Dependence on cell differentiation and modulation by calcitriol
115. 3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells
116. 3 pretreatment limits prostaglandin biosynthesis by cytokine-stimulated adult human osteoblast-like cells
117. 3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures
118. Osteonectin in matrix remodeling. A plasminogen-osteonectin-collagen complex
119. 3 interaction with dexamethasone and retinoic acid: Effects on procollagen messenger ribonucleic acid levels in rat osteoblast-like cells
120. 3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene
121. Cell density-dependent vitamin D effects on calcium accumulation in rat osteogenic sarcoma cells (ROS 17/2)
122. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements
123. Inositol trisphosphate receptor gene expression and hormonal regulation in osteoblast-like cell lines and primary osteoblastic cell cultures
124. 3 on proliferation and vitamin D receptor expression of rat growth cartilage cells
125. Targets of activated steroid hormone receptors: Basal transcription factors and receptor interacting proteins
126. Mineralization ability of cultured human osteoblast-like periosteal cells does not decline with aging
127. 3-induced mineralization in human periosteal osteoblasts
128. Turning a negative into a positive: Vitamin D receptor interactions with the avian parathyroid hormone response element
129. 3 on interleukin-6 synthesis induced by prostaglandins in osteoblasts
130. 2+ influx by steroid hormones in osteoblast-like cells
131. 2+ exchange protein in osteoblastic cells
132. 3 in bone from genetic hypercalciuric rats
133. 3 receptors by parathyroid hormone in osteoblastic cells: Role of second messenger pathways
134. 3 receptor gene expression and enhances hormone action
135. 3 in the transcriptional control of type I collagen synthesis in MC3T3-E1 osteoblastic cells
136. 3 on regulation of function in clonal osteoblastic cells
137. 3
138. 3
139. Osteocalcin secretion by the human osteosarcoma cell line MG-63
140. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63
141. Apoptosis is coordinately regulated with osteoblast formation during bone healing
142. Characterization of vitamin D receptor immunoreactivity in human bone cells
143. 3 receptor- and retinoid X receptor-mediated gene activation in vivo
144. Cloning and characterization of the rat bone sialoprotein gene promoter
145. Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption
146. 3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin
147. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia
148. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression
149. Species-specific gluco-corticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: Dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression
150. The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGF-β1) and hormones (vitamin D and glucocorticoids)
151. 3 metabolites on cytosolic free calcium in confluent mouse osteoblasts
152. 3 on the phosphoinositide metabolism in rat enterocytes
153. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8)
154. Estrogen increases 1,25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa
155. TGF-β1 modifications in nuclear matrix proteins of osteoblasts during differentiation
156. 3
157. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro
158. Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors
159. Regulation of osteogenic differentiation of human bone marrow stromal cells: Interaction between transforming growth factor-β and 1,25(OH)(2) vitamin D(3) in vitro
160. 3 and binds the vitamin D3 receptor
161. Characterization of endosteal osteoblastic cells isolated from mouse caudal vertebrae
162. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
163. 3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity
164. Apoptosis during bone-like tissue development in vitro
165. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization
166. The vitamin D receptor interacts with general transcription factor IIB
167. 3 and activates protein C at their cell membrane
168. 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells
169. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts
170. In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: Relationship with cell proliferation
171. The plasminogen activator and inhibitor system in bone remodelling
172. 3-induced response of various osteoblastic markers in human osteoblastic cells
173. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction
174. Simultaneous induction of apoptosis, collagen type I expression and mineralization in the developing coronal suture following FGF4 and FGF2 application
175. 3 enhancement of osteopontin gene expression
176. 3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells
177. 3 on phospholipid metabolism in a clonal osteoblast-like rat osteogenic sarcoma cell line
178. Constitutive synthesis of insulin-like growth factor-II by primary osteoblast-enriched cultures from fetal rat calvariae
179. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption
180. Demonstration of vitamin D receptor transcripts in actively resorbing osteoclasts in bone sections
181. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines
182. Bone-derived growth factors modulate collagenase and TIMP (tissue inhibitor of metalloproteinases) activity and type I collagen degradation by mouse calvarial osteoblasts
183. 3 hypersensitivity of osteoclast precursors from patients with Paget's disease
184. 3 production. Studies in cultured mouse kidney cells
185. 3, and thyroid hormone receptors in mammalian cells
186. 1,25-Dihydroxyvitamin D(3) induction of the tissue-type plasminogen activator gene is mediated through its multihormone-responsive enhancer
187. 3 in seven human prostatic carcinoma cell lines
188. 3
189. 3 regulation of proliferation and alkaline phosphatase activity in late-passage rat osteoblastic cell lines
190. 3 and its analogues in rat osteoblast-like cells
191. Vitamin D for the treatment of osteoporosis
192. Studies on the regulation of insulin-like growth factor binding protein 3 secretion in human osteosarcoma cells in vitro
193. Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia
194. 3 on insulin-like growth factor-binding protein-5 mRNA expression in osteoblastic UMR-106 cells: The difference between transient and continuous treatments
195. 3 which mediates rapid activation of protein kinase C
196. 3 recombinant human transforming growth factor-β1, and recombinant human bone morphogenetic protein-2 induce in vitro differentiation of canine osteosarcoma cells
197. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteopenic disorders
198. Osteo-protegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria
199. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro
200. Regulation of bone sialoprotein mRNA by steroid hormones
201. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: Dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures
202. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: Model for phenotype suppression of transcription
203. 3, parathyroid hormone, and dexamethasone
204. The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer
205. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
206. 3 on TNFα-mediated apoptosis of human primary osteoblast-like cells in vitro
207. 3
208. 3 receptor levels in tumor and nontumor cells derived from rat bone
209. 3 binding in rat osteosarcoma cells
210. 3 increases epidermal growth factor receptors and transforming growth factor β-like activity in a bone-derived cell line
211. Signal transduction by retinoid receptors
212. Evidence that the self-induced metabolism of 1,25-dihydroxyvitamin D-3 limits the homologous up-regulation of its receptor in rat osteosarcoma cells
213. 3 on growth, alkaline phosphatase and adenylate cyclase of rat osteoblast-like cells
214. 3 receptor by parathyroid hormone (PTH) and PTH-like peptide in osteoblast-like cells
215. Gla-containing proteins of bone
216. 3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells
217. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: An in vitro model of osteoblast development
218. 3 response element of chicken carbonic anhydrase-II
219. Mechanisms of gene regulation by vitamin D(3) receptor: A network of coactivator interactions
220. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex
221. 3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system
222. Prostaglandins and bone: Physiology and pathophysiology
223. Characterization of human osteoblastic cells: Influence of the culture conditions
224. Fos and Jun bind cooperatively to the AP-1 site: Reconstitution in vitro
225. 3 receptors synergistically in rat osteosarcoma cells
226. Osteopontin - A possible anchor of osteoclasts to bone
227. 3 and the nonadherent cells of marrow for osteoblast differentiation from rat marrow stromal cells
228. The role of gp130-mediated signals in osteoclast development: Regulation of interleukin 11 production by osteo-blasts and distribution of its receptor in bone marrow cultures
229. Serum insulin-like growth factors and insulin-like growth factor-binding proteins: Clinical implications
230. 3
231. 3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts
232. 3 increases secretion of insulin-like growth factor binding protein-4 (IGFBP-4) by human osteoblast-like cells in vitro and elevates IGFBP-4 serum levels in vivo
233. 3 induces the expression of vascular endothelial growth factor in osteoblastic cells
234. 3 increases IGF binding protein-5 expression in cultured osteoblasts
235. 3 responsive immediate early gene in human fetal osteoblasts: Regulation by cytokines, growth factors, and serum
236. 3 in three osteoblast-like cell lines (MC3-T3-E1 ROS 17/2.8, and MG-63)
237. Multiple levels of steroid hormone-dependent control of osteocalcin during osteoblast differentiation: Glucocorticoid regulation of basal and vitamin D stimulated gene expression
238. Role of vitamin K and gla proteins in the pathophysiology of osteoporosis and vascular calcification
239. Characterization and hormonal modulation of IL-I binding in neonatal mouse osteoblast-like cells
240. 3 modulation in lipid metabolism in established bone marrow-derived stromal cells, MC3T3-G2/PA6
241. Development of the osteoblast phenotype in primary human osteoblasts in culture: Comparison with rat calvarial cells in osteoblast differentiation
242. 3 attenuates the confluence-dependent differences in the osteoblast characteristic proteins alkaline phosphatase, pro-collagen I peptide, and osteocalcin
243. Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro
244. Constitutive and inducible expression of HLA class II determinants by human osteoblast-like cells in vitro
245. Role of chondroitin sulfate glycosaminoglycans in mineralizing osteoblast-like cells: Effects of hormonal manipulation
246. Steroid receptor coactivator-1 is a histone acetyltransferase
247. Tissue specificity and mechanism of vitamin D receptor up-regulation during dietary phosphorus restriction in the rat
248. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D
249. Constitutive expression of calreticulin in osteoblasts inhibits mineralization
250. 3 action in osteoblast-like cells
251. 3 in mouse long bones: Interaction with the bone-derived growth factors TGF-β and IGF-I
252. 3-induced 24-hydroxylase activity in osteoblast-like cells: Initiation of the C24-oxidation pathway
253. Distinct conformations of vitamin D receptor/retinoid X receptor-α heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes
254. 3 enhancement of osteocalcin and osteopontin transcription: Reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements
255. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype
256. Bone cell differentiation: A functionally coupled relationship between expression of cell-growth- and tissue-specific genes
257. Transcriptional control of osteoblast growth and differentiation
258. 3-mediated transforming growth factor-β release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies
259. Role of vitamin D in bone resorption
260. Effects of high calcium concentration on the functions and interactions of osteoblastic cells and monocytes and on the formation of osteoclast-like cells
261. 3 on prostaglandin E2 synthesis in osteoblast-like cells
262. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: Studies using VDR knock-out mice
263. 3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts
264. Prostaglandin D2 metabolite stimulates collagen synthesis by human osteoblasts during calcification
265. 3
266. Species-divergent regulation of human and mouse osteocalcin genes by calciotropic hormones
267. Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: Evidence for a plasminogen-plasmin-metalloproteinase activation cascade
268. 3 and inhibited by human recombinant TIMP (tissue inhibitor of metalloproteinases)
269. Treatment of postmenopausal osteoporosis with calcitriol or calcium
270. 3 on signaling by prostaglandin E2 in osteoblast-like cells
271. Production of interleukin-6 by osteoblastic cells is independent of medium inorganic phosphate
272. Potential role of insulinlike growth factors in fracture healing
273. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element
274. Possible involvement of the p57 (Kip2) gene in bone metabolism
275. 3 analog KH1060
276. 3-analogs on osteoblast-like cells and on in vitro bone resorption
277. 3
278. 3 receptor in osteoblast-like cells
279. 3 receptor
280. 3 receptor in an osteoblast cell line
281. 3 and parathyroid hormone
282. 3 receptor gene expression by parathyroid hormone and cAMP-agonists
283. 3 receptor in clonal osteoblast-like cells
284. 3 and bone metabolism
285. 3-mediated nerve growth factor expression in osteoblasts
286. Modulation of bone morphogenetic protein-2 and bone morphogenctic protein-4 gene expression in osteoblastic cell lines
287. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
288. 3 stimulates membrane phosphoinositide turnover, activates protein kinase C, and increases cytosolic calcium in rat colonic epithelium
289. 3 receptor in rat uterus
290. 1,25-Dihydroxyvitamin D receptors in an established bone cell line. Correlation with biochemical responses
291. 3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells
292. 3 in human osteoblast-like cells
293. Recombinant human bone morphogenetic protein induces bone formation
294. 3′ 17 β-estradiol, and testosterone is age dependent in primary cultures of mouse-derived osteoblasts in vitro
295. Clinical utility of biochemical markers of bone remodeling
296. Management of osteoporosis: Is there a role for vitamin K?
297. Local action of exogenous growth hormone and insulin-like growth factor-I on dihydroxyvitamin D production in LLC-PK1 cells
298. Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D
299. 3
300. Insulin-like growth factor-I stimulates renal 1, 25-dihydroxychole-calciferol synthesis in old rats fed a low calcium diet
301. 3: Increased bone but impaired mineralization
302. 3 response elements in the human transforming growth factor-β2 gene
303. 3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone cells
304. Positive and negative modulation of vitamin D receptor function by transforming growth factor-β signaling through smad proteins
305. Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators
306. 3 upregulates natriuretic peptide receptor-C expression in mouse osteoblasts
307. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption
308. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning
309. Structure, expression, and regulation of the major noncollagenous matrix proteins of bone
310. 3 inhibits osteocalcin expression in mouse through an indirect mechanism
311. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines